The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

State lawmakers unsuccessfully attempted to extend the law this year to cover the intentional exposure of other sexually ...